Table 3.

Fold changes in numbers of viable cells normalized relative to TC for various sDNA transfections as a function of gemcitabine treatment.

	sDNA used for transfection	Gemcitabine (nM)
		0	1	10	30	100	1000
Miapaca-2 (0.1 μg)	TC	1.00	1.00	−1.30	−3.21	−3.59	−3.47
	Mix	1.07	1.12	1.01	−2.65	−4.41	−4.48
	CG	1.09	1.12	1.09	3.29	4.06	4.24
	AT	−1.52	−1.38	−1.79	−7.07	−9.58	−6.82
Miapaca-2 (0.25 μg)	TC	1.00	1.00	−1.30	−3.21	−3.59	−3.47
	CG	−1.30	−1.38	−1.37	−2.97	−5.48	−4.11
	AT	−3.68	−4.45	−4.14	−8.32	−11.81	−11.31
AsPC-1 (0.1 μg)	TC	1.00	1.14	−1.02	−1.04	−1.36	−1.52
	Mix	−1.14	−1.06	−1.16	−1.17	−1.36	−1.59
	CG	−1.11	−1.09	−1.18	−1.34	−1.52	−1.67
	AT	−1.44	−1.58	−1.71	−1.86	−2.04	−2.33
AsPC-1 (0.25 μg)	TC	1.00	1.14	−1.02	−1.04	−1.36	−1.52
	CG	−1.10	−1.10	−1.21	−1.69	−1.36	−2.16
	AT	−1.65	−1.92	−2.63	−2.66	−2.83	−4.32